TEVA financials
Teva (TEVA) financials: revenue, profit and margins by year and quarter, the balance sheet and cash flow.
TEVA income statement, yearly
| Year | Revenue | Gross profit | Operating income | Net income | EPS |
|---|---|---|---|---|---|
| 2025 | $17.26B | $8.94B | $2.16B | $1.41B | 1.20 |
| 2024 | $16.54B | $8.06B | -$303.00M | -$1.64B | -1.45 |
| 2023 | $15.85B | $7.64B | $433.00M | -$559.00M | -0.50 |
| 2022 | $14.93B | $6.97B | -$2.20B | -$2.45B | -2.20 |
| 2021 | $15.88B | $7.59B | $1.72B | $417.00M | 0.38 |
| 2020 | $16.66B | $7.73B | -$3.57B | -$3.99B | -3.64 |
- TEVA revenue was $17.26B in fiscal 2025, net income $1.41B.
Updated 2026-11-02 19:20 UTC